Specialties
Gynecology and obstetrics
Expertises
Map and access information
Gynéviva
Goethestrasse 24
8001 Zürich
Opening hours
Monday:
08:00 - 14:00 and 15:00 - 19:00
Tuesday:
08:00 - 14:00 and 15:00 - 19:00
Wednesday:
08:00 - 14:00 and 15:00 - 19:00
Thursday:
08:00 - 14:00 and 15:00 - 19:00
Friday:
08:00 - 14:00 and 15:00 - 19:00
Saturday:
09:00 - 16:00
Sunday:
09:00 - 16:00
Presentation of the healthcare professional
Spoken languages
German, English, French and Italian
Website
FAQ
expand_moreWhat is the address of Dr. med. Kristina Bolten?
Dr. med. Kristina Bolten receives patients at Goethestrasse 24, 8001 Zürich .
What languages does Dr. med. Kristina Bolten speak?
Dr. med. Kristina Bolten offers consultations in German, English, French and Italian.
What are Dr. med. Kristina Bolten's consulting hours?
The consultation hours of Dr. med. Kristina Bolten are:
Gynéviva
: Goethestrasse 24, 8001 Zürich- On Monday from 08:00 to 14:00 and from 15:00 to 19:00
- On Tuesday from 08:00 to 14:00 and from 15:00 to 19:00
- On Wednesday from 08:00 to 14:00 and from 15:00 to 19:00
- On Thursday from 08:00 to 14:00 and from 15:00 to 19:00
- On Friday from 08:00 to 14:00 and from 15:00 to 19:00
- On Saturday from 09:00 to 16:00
- On Sunday from 09:00 to 16:00
What is Dr. med. Kristina Bolten's website?
You can access the website of Dr. med. Kristina Bolten at https://www.gyne-viva.ch/ open_in_new .
What is Dr. med. Kristina Bolten's phone number?
The phone number of Dr. med. Kristina Bolten is 044 365 12 12.
Does Dr. med. Kristina Bolten accept new patients?
Yes, Dr. med. Kristina Bolten accepts new patients. New patients can easily book appointments online via OneDoc.
What are Dr. med. Kristina Bolten's specialties?
Dr. med. Kristina Bolten performs gynecology and obstetrics in Zürich.
What are Dr. med. Kristina Bolten's expertises?
Dr. med. Kristina Bolten's expertises in Zürich are: Breast cancer, Ovarian cancer, Endometriosis, Uterine cancer, HPV | Humane papillomavirus vaccination, Colposcopy, Vaginal cancer, Breast cancer screening and Vulvar cancer.